tyrosine has been researched along with Disease Exacerbation in 175 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (5.71) | 18.2507 |
| 2000's | 79 (45.14) | 29.6817 |
| 2010's | 74 (42.29) | 24.3611 |
| 2020's | 12 (6.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bustuoabad, OD; Chiarella, P; Duarte, A; Montagna, DR; Rearte, B; Ruggiero, RA; Vermeulen, M | 1 |
| Bäckhed, F; Buffa, JA; Demuth, I; Fischbach, MA; Haghikia, A; Hazen, SL; König, M; Landmesser, U; Li, L; Li, XS; Nemet, I; Romano, KA; Steinhagen-Thiessen, E; Tang, WHW; Wilcox, J; Witkowski, M | 1 |
| Brucker, DP; Filipski, K; Filss, CP; Galldiks, N; Hattingen, E; Langen, KJ; Maurer, GD; Mottaghy, FM; Steinbach, JP; Stoffels, G | 1 |
| Akhoundova, D; Andratschke, N; Bankel, L; Curioni-Fontecedro, A; Förster, R; Hiltbrunner, S; Hüllner, M; Kollias, S; Kraft, J; Lee, SY; Mader, C; Rushing, EJ; Schwanhäusser, B; Treyer, V | 1 |
| Dickson, FH; Nabi, IR; Timmins, LR; Wong, TH | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Abdulla, DSY; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Hüllner, M; Kocher, M; Kreuzberg, N; Landsberg, J; Langen, KJ; Lohmann, P; Marnitz, S; Mauch, C; Ruge, MI; Scheffler, M; Schlaak, M; Schweinsberg, V; Stoffels, G; Tonn, JC; Trommer, M; Weller, M; Werner, JM; Wolf, J; Wolpert, F | 1 |
| Borgaonkar, M; Lim, DR; Phua, C; Vidyasankar, G | 1 |
| Bailey, WM; Gensel, JC; McFarlane, KE; Patel, SP; Slone, SA; Stewart, AN; Sullivan, PG; Tranthem, LA; Vekaria, HJ; Zhang, B | 1 |
| Bauer, EK; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Gielen, GH; Herrlinger, U; Kabbasch, C; Langen, KJ; Lohmann, P; Marnitz, S; Schäfer, N; Schaub, C; Stoffels, G; Tscherpel, C; Weller, J; Werner, JM | 1 |
| Bijak, M; Kowal, P; Marchewka, Z; Saluk-Bijak, J; Sawicka, E; Szymańska, B; Wigner, P | 1 |
| Bahri, MA; Becker, G; Bezard, E; Caruso, M; Citron, M; De Wolf, C; Deprez, T; Downey, P; Frequin, JM; Freyssin, A; Garraux, G; Gillent, E; Hustadt, F; Jacquin, L; Lemaire, C; Luxen, A; Mairet-Coello, G; Michel, A; Plenevaux, A | 1 |
| Abate, ML; Bugianesi, E; Buzzigoli, E; Carli, F; Cassader, M; Ciociaro, D; Della Latta, V; Gaggini, M; Gambino, R; Gastaldelli, A; Marietti, M; Rosso, C | 1 |
| Dong, Y; Liu, H; Luo, C; Sun, Q; Wang, H; Wang, W; Wu, Y; Xu, J; Zhang, H; Zhou, Y | 1 |
| Inoue, J; Iwata, T; Kakazu, E; Kogure, T; Morosawa, T; Nakamura, T; Ninomiya, M; Sano, A; Shimosegawa, T; Takai, S; Umetsu, T | 1 |
| Atkins, KB; Brosius, FC; Byun, J; Mathew, AV; Pennathur, S; Zeng, L | 1 |
| Gielen, GH; Giordano, FA; Glas, M; Herrlinger, U; Kebir, S; Lazaridis, L; Rauschenbach, L; Schäfer, N; Scheffler, B; Tzaridis, T | 1 |
| Attems, J; Daum, G; Flunkert, S; Hoeller, C; Hutter-Paier, B; Kerschbaumer, B; Loeffler, T; Neddens, J; Niederkofler, V; Temmel, M | 1 |
| Bauer, EK; Ceccon, G; Dunkl, V; Fink, GR; Galldiks, N; Henriksen, OM; Langen, KJ; Law, I; Lohmann, P; Muhic, A; Poulsen, HS; Schmidt, M; Shah, NJ; Steger, J; Stoffels, G; Tscherpel, C | 1 |
| Anthony, DC; Claridge, TDW; Jagielowicz, M; Probert, F; Simmons, A; Travis, S; Walsh, A; Yeo, T | 1 |
| Adam, D | 1 |
| Groeneveld, ME; Hoksbergen, AWJ; Koolwijk, P; Musters, RJP; Niessen, HW; Struik, JA; Tangelder, GJ; Wisselink, W; Yeung, KK | 1 |
| Gao, H; Li, W; Liang, J; Liu, R; Tao, B; Wang, C; Wang, X; Yang, W; Yang, Z; Zhang, Y | 1 |
| Baraldi, E; D'Andrea, G; Giordano, G; Gucciardi, A; Leon, A; Pizzolato, G; Stocchero, M | 1 |
| Borggrefe, J; Ceccon, G; Fink, GR; Galldiks, N; Kabbasch, C; Langen, KJ; Lichtenstein, T; Lohmann, P; Shah, NJ; Stoffels, G; Werner, JM | 1 |
| Brumberg, J; Ernestus, RI; Kertels, O; Kessler, AF; Kircher, M; Lapa, C; Linsenmann, T; Löhr, M; Meyer, PT; Mihovilovic, MI; Monoranu, CM; Samnick, S; Tran-Gia, J | 1 |
| Chan, L; Corbalán-Campos, J; Hartmann, P; Heyll, K; Nazari-Jahantigh, M; Schober, A; Thiemann, A; Weber, C; Wei, Y; Zhu, M | 1 |
| Bendotti, C; Biggio, ML; Dyall, SC; Gladman, S; Jayasinghe, M; Malaspina, A; Marino, M; Michael-Titus, A; Pizzasegola, C; Ullah, F; Yip, PK | 1 |
| Assaf, Y; Giladi, E; Gozes, I; Jouroukhin, Y; Ostritsky, R; Pelled, G | 1 |
| Fujita, T; Kawakami-Mori, F; Mu, S; Ogura, S; Shimosawa, T; Shirai, M; Sonobe, T; Uetake, Y; Wang, H; Yatomi, Y; Yoshida, K | 1 |
| Coenen, HH; Erdem, Z; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Reifenberger, G; Ruge, MI; Sabel, M; Shah, NJ; Stoffels, G | 1 |
| Bartenstein, P; Drexler, M; Eigenbrod, S; Jansen, NL; Kreth, FW; la Fougère, C; Niyazi, M; Schmid-Tannwald, C; Schnell, O; Suchorska, B; Thon, N; Tonn, JC; Wenter, V; Zwergal, A | 1 |
| Santa-Cruz, LD; Tapia, R | 1 |
| Bendlin, BB; Buyan-Dent, L; Christian, BT; DeJesus, OT; Gallagher, CL; Harding, SJ; Holden, JE; Li, CT; Nickles, RJ; Oh, J; Okonkwo, O; Palotti, M; Stone, CK | 1 |
| Donnola, S; Eswarappa, SM; Fan, Y; Fox, PL; Gong, Y; Hambardzumyan, D; Lathia, JD; Potdar, AA; Rich, JN | 1 |
| Castela, A; Costa, C; Costa, R; Domingues, VF; Gomes, P; Paíga, P; Vendeira, P | 1 |
| Förster, S; Gempt, J; Hüttinger, S; Nekolla, S; Pyka, T; Ringel, F; Schwaiger, M; van Marwick, S; Wester, HJ | 1 |
| Abdul Nasir, NA; Agarwal, R; Alyautdin, R; Ismail, NM; Tripathy, M; Vasudevan, S | 1 |
| Hirakawa, K; Ishino, T; Kubota, K; Takeno, S; Taruya, T; Yoshimura, H | 1 |
| Dalekos, GN; Kaffe, ET; Koukoulis, GK; Moulas, AN; Rigopoulou, EI | 1 |
| Chatterjee, S; Das, S; Dattaroy, D; Diehl, AM; Fan, D; Igwe, S; Michelotti, GA; Pourhoseini, S; Ray, JB; Seth, RK | 1 |
| Blau, T; Dorn, F; Drzezga, A; Dunkl, V; Fink, GR; Galldiks, N; Goldbrunner, R; Hau, P; Herrlinger, U; Hutterer, M; Kebir, S; Kocher, M; Langen, KJ; Rapp, M; Reifenberger, G; Ruge, MI; Sabel, M; Schmidt, M; Stoffels, G | 1 |
| Andersen, SB; Bøgeskov, L; Cleff, C; Coenen, HH; Dunkl, V; Fink, GR; Galldiks, N; Judov, N; Langen, KJ; Law, I; Nysom, K; Reifenberger, G; Sarikaya-Seiwert, S; Shah, NJ; Steiger, HJ; Stoffels, G | 1 |
| Brzozowa, M; Kabiesz, A; Majewski, W; Reichman-Warmusz, E; Rokicki, W; Wojnicz, R; Wyględowska-Promieńska, D; Żaba, M | 1 |
| Gu, L; Lee, S; Li, GM; Li, JY; Ortega, J; Tong, D | 1 |
| Ahmad, A; Bruschetta, G; Crupi, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Paterniti, I; Prosdocimi, M; Siracusa, R | 1 |
| Blau, T; Ceccon, G; Dunkl, V; Filss, C; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Shah, NJ; Stoffel, M; Stoffels, G; Tscherpel, C; Weinzierl, M | 1 |
| Csont, T; Erdélyi, K; Godó, M; Hamar, P; Kaucsár, T; Kiss, N; Kökény, G; Krenács, T; Lajtár, E; Pacher, P; Révész, C; Sárközy, M; Szalay, CI; Szénási, G | 1 |
| Blake, J; Carr, AS; Evans, MR; Gillmore, JD; Hawkins, PN; Iodice, V; Laurà, M; Pelayo-Negro, AL; Reilly, MM; Stancanelli, C; Wechalekar, AD; Whelan, CJ | 1 |
| Fujita, Y; Furuta, N; Ikeda, M; Ikeda, Y; Ishizawa, K; Makioka, K; Motomura, M; Nagamine, S; Okamoto, K; Shibata, M; Tsukagoshi, S; Yoshimura, S | 1 |
| Fimmers, R; Galldiks, N; Glas, M; Herrlinger, U; Kebir, S; Langen, KJ; Mack, F; Niessen, M; Schäfer, N; Schaub, C; Scheffler, B; Simon, M; Stoffels, G; Stuplich, M; Tzaridis, T | 1 |
| Harat, M; Makarewicz, R; Małkowski, B | 1 |
| Akao, H; Aoki, H; Fujibayashi, K; Kajinami, K; Kawai, Y; Kitayama, M; Motoyama, A; Nakanishi, H; Saito, K; Saito, R; Takeuchi, M; Tsuchiya, T; Wakasa, M; Watanabe, M | 1 |
| Bauer, E; Ceccon, G; Filss, CP; Fink, GR; Galldiks, N; Hamisch, C; Judov, N; Kocher, M; Kuchelmeister, K; Langen, KJ; Lohmann, P; Rapp, M; Ruge, MI; Sabel, M; Sellhaus, B; Shah, NJ; Stoffels, G | 1 |
| Li, YF; Liu, Y; Long, YH; Wang, SQ; Zhang, JH | 1 |
| Bundschuh, RA; Essler, M; Fimmers, R; Gaertner, FC; Glas, M; Hattingen, E; Herrlinger, U; Kebir, S; Khurshid, Z; Scheffler, B | 1 |
| Costa, JC; Engelholm, SA; Law, I; Lundemann, M; Muhic, A; Munck Af Rosenschold, P; Poulsen, HS | 1 |
| Adamczyk-Sowa, M; Bartosz, G; Bieszczad-Bedrejczuk, E; Czyżewski, D; Galiniak, S; Rozmiłowska, I; Sadowska-Bartosz, I | 1 |
| Astigiano, S; Barisione, G; Cassanello, M; Cesario, A; Costa, R; Fabbi, M; Ferlazzo, G; Ferrini, S; Frumento, G; Grossi, F; Mastracci, L; Morandi, B; Piazza, T; Ratto, GB; Rotondo, R; Sormani, MP | 1 |
| Albitar, L; Aponte, M; Cramer, DW; Edwards, D; Jiang, W; Lakkis, M; Li, MJ; Mok, SC; Vitonis, A; Ye, B | 1 |
| Higo, S; Jiang, QY; Kasuga, M; Kitazawa, R; Kitazawa, S; Miyata, S | 1 |
| Dutta, U; Shaw, LM | 1 |
| Chang, CF; Koay, ES; Wong, LL; Zhang, D | 1 |
| Elliott, BE; Foley, JH; Jia, Z; Li, JJ; Miller, F; Singh, VK; Wright, TG | 1 |
| Hooper, DC; Jacobs, D; Koprowski, H; Markowitz, CE; Spitsin, S; Udupa, JK; Zimmerman, V | 1 |
| Jung, KJ; Kim, J; Park, KM; Seok, YM | 1 |
| Ben-Izhak, O; Cohen-Kaplan, V; Nagler, RM | 1 |
| Adams, JR; Ely, EW; Girard, TD; Morandi, A; Pandharipande, PP; Shintani, AK; Thompson, JL | 1 |
| Funakoshi, H; Kadoyama, K; Matsumoto, K; Matsuyama, S; Nakamura, T; Ohya-Shimada, W | 1 |
| Allameh, A; Nasseri-Moghaddam, S; Rasmi, Y; Sadreddini, M; Sharifi, R; Tavangar, SM | 1 |
| Glahn, J; Philipps, J; Rother, J; Schwarze, M; Thomalla, G | 1 |
| Aracil, E; Gómez, M; Lavin, B; Lizarbe, TR; Orte, LM; Tarín, C; Zaragoza, C | 1 |
| Basso, M; Bendotti, C; Bonetto, V; Cantoni, L; Cheroni, C; D'Alessandro, G; De Biasi, S; Estevez, AG; Giordana, MT; Marino, M; Massignan, T; Nardo, G; Salmona, M; Samengo, G; Strong, MJ; Tartari, S | 1 |
| Barrette, S; Béliveau, R; Gingras, D; Nyalendo, C; Ohta, S; Sartelet, H | 1 |
| Ansari, MA; Scheff, SW | 1 |
| Ansari, GA; Khan, MF; Papalardo, E; Pierangeli, SS; Wang, G | 1 |
| Challa, S; Chen, YA; Cheng, JQ; Coppola, D; Earp, HS; Engelman, RW; Fang, B; Koomen, J; Lopez, AS; Mahajan, K; Mahajan, NP; Muraoka-Cook, RS; Rivera, C; Schönbrunn, E; Sebti, SM; Zhu, W | 1 |
| Andjelkovic, AV; Hoffman, WH; Passmore, GG; Sima, AA; Zhang, W | 1 |
| Chen, CH; Liu, WW; Manaenko, A; Ostrowki, RP; Tang, J; Zhan, Y; Zhang, JH | 1 |
| Andreadou, I; Filis, K; Gorgoulis, VG; Iliodromitis, EK; Kotsinas, A; Markantonis, S; Savari, P; Sigala, F | 1 |
| Bhaskar, K; Hobbs, GA; Lee, G; Yen, SH | 1 |
| Alzualde, A; Atares, B; Barandiaran, M; Calero, M; Estanga, A; Ferrer, I; Gorostidi, A; Indakoetxea, B; Juste, R; López de Munain, A; Moreno, F; Rodriguez-Martínez, AB; Ruiz, I; van Leeuwen, FW | 1 |
| Balding, E; Berry, LJ; Brennan, S; Carlin, JB; Carzino, R; Chapman, AL; de Klerk, N; Douglas, T; Foo, C; Gangell, CL; Garratt, LW; Hall, GL; Harrison, J; Kettle, AJ; Kicic, A; Laing, IA; Logie, KM; Massie, J; Mott, LS; Murray, C; Parsons, F; Pillarisetti, N; Poreddy, SR; Ranganathan, SC; Robertson, CF; Robins-Browne, R; Robinson, PJ; Senthilmohan, R; Skoric, B; Sly, PD; Stick, SM; Sutanto, EN; Thomson, E; Williamson, E | 1 |
| Béliveau, R; Gingras, D; Nyalendo, C; Sartelet, H | 1 |
| Feng, W; Hua, P; Jaimes, EA; Ji, S; Raij, L | 1 |
| Bernabei, C; Bragato, C; Chiari, A; Gellera, C; Georgoulopoulou, E; Mandrioli, J; Sola, P | 1 |
| Butterfield, DA; Reed, T; Sultana, R | 1 |
| Barabé, F; Gilbert, C; Lambert, AA; Tremblay, MJ | 1 |
| Chen, Y; Choong, LY; Lim, SK; Lim, YP; Loh, MC; Salto-Tellez, M; Shah, N; Toy, W; Wong, CY | 1 |
| Baez, A; Córdoba, R; Dominguez, R; Fretes, R; Guzman Mentesana, G; Lo Presti, S; Paglini-Oliva, P; Pons, P; Rivarola, W | 1 |
| Christensen, ME; He, Y; Hooper, JD; Linn, M; Lumley, JW; Pollock, PM; Waterhouse, NJ; Wortmann, A | 1 |
| Bolton, S; Cadogan, EB; Churg, A; Mallinder, PR; Maltby, J; Marshall, CV; Sin, DD; Soars, MG; Thain, K; Wright, JL; Zhou, S | 1 |
| Majsterek, I; Miller, E; Ponczek, MB; Saluk, J; Walczak, A | 1 |
| Ishihara, A; Kihira, K; Kimura, Y; Matsumoto, M; Miyachi, T; Nakamura, T; Ohtsuki, T; Yamawaki, T | 1 |
| Castro, NE; Daniel, AR; Lange, CA; Locatelli, A; Lofgren, KA | 1 |
| Bagi, Z; Feher, A; Huang, A; Kaley, G; Sun, D; Yang, YM | 1 |
| Coenen, HH; Eble, MJ; Filss, CP; Fink, GR; Galldiks, N; Holy, R; Kaiser, HJ; Langen, KJ; Nolte, KW; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
| Alam, K; Dixit, K; Khan, MA; Malik, A; Uddin, M | 1 |
| Abdelkader, A; Broughton, BR; Ding, A; Evans, RG; Kalaignanasundaram, P; Kim, HB; Phillips, JK; Ricardo, SD; Witting, PK; Wyse, BF | 1 |
| Anantharam, V; Dranka, BP; Ghosh, A; Joseph, J; Kalyanaraman, B; Kanthasamy, A; Kanthasamy, AG; Srivastava, P | 1 |
| Arribas, SM; Condezo-Hoyos, L; España-Caparrós, G; González, MC; Mujica-Pacheco, E; Rodríguez-Rodríguez, P; Rubio, M | 1 |
| Akedo, H; Iwasaki, T; Mukai, M; Nakamura, H; Tatsuta, M; Terada, N; Tsujimura, T | 1 |
| Dubner, R; Guan, Y; Guo, W; Ikeda, T; Ren, K; Tal, M; Zou, S | 1 |
| Bayer, AL; Engman, SJ; Heidkamp, MC; Patel, N; Porter, MJ; Samarel, AM | 1 |
| Bousquet, B; Garnier, JP; Ghanem, G; Le Bricon, T; Letellier, S; Morel, P; Stoitchkov, K; Tsankov, N | 1 |
| Ballinger, SW; Burow, DL; Conklin, CA; Horaist, C; Hu, Z; Hunter, GC; Knight-Lozano, CA; Lebovitz, R; McIntyre, K; Patterson, C; Reuf, J; Runge, MS | 1 |
| Chade, AR; Grande, JP; Krier, JD; Lerman, A; Lerman, LO; Napoli, C; Rodriguez-Porcel, M; Romero, JC | 1 |
| Koppolu, P; Kowluru, RA | 1 |
| Lamensdorf, I; Lavie, G; Leker, RR; Ovadia, H; Shohami, E; Teichner, A | 1 |
| Horton, ES; Komjáti, K; Krolewski, AS; LoGerfo, FW; Pacher, P; Quist, WC; Szabó, C; Veves, A; Zanchi, A | 1 |
| Anderson, PD; Anikster, Y; Bernardini, I; Fitzpatrick, DL; Gahl, WA; Gerber, LH; Huizing, M; Introne, WJ; Murphey, MD; Perry, MB; Phornphutkul, C | 1 |
| Banik, NL; Dasgupta, S; Jana, M; Pahan, K; Zhou, Y | 1 |
| Bagnato, A; Di Castro, V; Natali, PG; Nicotra, MR; Rosanò, L; Spinella, F | 1 |
| Boonstra, FN; Brunner, HG; Cremers, FP; Koenekoop, RK; Kroes, HY; Schuil, J; van den Born, LI; van den Helm, B; van Genderen, MM; Yzer, S | 1 |
| Mizukami, H; Ozawa, K; Saga, Y; Suzuki, M; Takei, Y | 1 |
| Ayers, LW; Basuray, A; Bauer, JA; Chaves, AA; Liu, C; Mihm, MJ; Schanbacher, BL | 1 |
| Brockman, D; Fagin, JA; Kim, HW; Knauf, JA; Millhorn, DE; Mitsutake, N; Moretti, S; Myatt, L; Puxeddu, E; Seta, KA | 1 |
| Ahokas, RA; Bhattacharya, SK; Gerling, IC; Herring, PA; Lu, L; Postlethwaite, AE; Sun, Y; Warrington, KJ; Weber, KT; Wodi, LA | 1 |
| Hosokawa, M; Kobayashi, M; Kobayashi, T; Mori, Y; Okada, F; Sendo, F; Tada, M; Tazawa, H; Une, Y | 1 |
| Bao, F; Chen, Y; Dekaban, GA; Weaver, LC | 1 |
| Engstler, M; Hammarton, TC; Mottram, JC | 1 |
| Chiriboga, CA; Clayton, PT; De Vivo, DC; Ford, B; Hinton, V; Hyland, K; Pons, R; Sharma, R | 1 |
| Bertagnolli, MM; Carothers, AM; Hunt, DH; Javid, SH; Moran, AE; Redston, M | 1 |
| Chang, NS; Hsu, LJ; Lewis, J; Schultz, L; Su, M; Sze, CI | 1 |
| Beal, MF; Calingasan, NY; Chen, J; Kiaei, M; Kipiani, K | 1 |
| Hongo-Masuko, K; Kato, T; Nakamura, H; Nguyen, vT; Nishioka, K; Yudoh, K | 1 |
| Bai, R; Dettin, LE; Glazer, RI; Kopelovich, L; Kopleovich, L; Kozikowski, AP; Russell, RG; Wei, ZL; Yin, Y | 1 |
| Kobrinsky, NL; Sjolander, DE | 1 |
| Hosokawa, M; Kobayashi, M; Kobayashi, T; Okada, F; Tazawa, H | 1 |
| Larocque, D; Lukong, KE; Richard, S; Tyner, AL | 1 |
| Angulo, J; Drüeke, TB; Ivanovski, O; Ketteler, M; Lacour, B; Maizel, J; Massy, ZA; Meert, N; Mothu, N; Nguyen-Khoa, T; Nikolov, IG; Phan, O; Vanholder, R; Westenfeld, R | 1 |
| Brock, RW; Dorman, RB; MacMillan-Crow, LA; Saba, H; Shoemaker, JL; Wunder, C | 1 |
| Ducharme, A; Guertin, MC; He, Y; Ibrahim, R; Lavoie, J; Racine, N; Rouleau, JL; Schiffrin, EL; Touyz, RM; White, M; Whittom, L; Yao, G | 1 |
| Bijleveld, CM; Pierik, LJ; van Dael, CM; van Spronsen, FJ | 1 |
| Bulinski, JC; Eiserich, JP; Harper, RW; Kamaid, A; Kubala, L; Phung, AD; Soucek, K | 1 |
| Carlson, NG; Hill, KE; Rose, JW; Tsoi, VL; Warner, JE | 1 |
| Kanda, S; Kanetake, H; Miyata, Y | 1 |
| Ding, J; Ding, YM; Fang, XM; Liu, QS; Liu, ZJ; Luo, HS; Tong, SL; Yu, HG; Yu, JP; Zhang, XF; Zhou, YH | 1 |
| Abdul, HM; Ansari, MA; Butterfield, DA; Nath, A; Opii, WO; Sultana, R | 1 |
| Boger, R; Cambareri, F; Cutrupi, S; Enia, G; Finocchiaro, P; Maas, R; Martorano, C; Panuccio, V; Pizzini, P; Schulze, F; Tripepi, G; Zoccali, C | 1 |
| Hong, YH; Kim, HJ; Kim, MJ; Kim, SM; Lee, KW; Park, JH; Park, KS; Sung, JJ | 1 |
| Hall, ED; Rabchevsky, AG; Xiong, Y | 1 |
| Gordon, P; Lu, J; Mehrazin, M; Mitsumoto, H; Naini, A | 1 |
| Biswas, SK; de Faria, JB | 1 |
| Butterfield, DA; Coccia, R; De Marco, C; Keller, JN; Markesbery, WR; Perluigi, M; Reed, TT; Sultana, R | 1 |
| Hayashi, Y; Hirose, N; Katare, RG; Lee, GH; Maeda, H; Radhakrishnan, G; Rao, P; Sasaguri, S; Yamaguchi, T; Yamamoto, M | 1 |
| Krishnamurthy, S; Pandya, JD; Patel, SP; Rabchevsky, AG; Sullivan, PG | 1 |
| Al-Abed, Y; Harhaji, L; Maksimovic-Ivanic, D; Mangano, K; Metz, C; Miljkovic, D; Momcilovic, M; Nicoletti, F; Papaccio, G; Popadic, D; Stojanovic, I; Stosic-Grujicic, S | 1 |
| Cotter, RJ; Gundry, R; Li, W; Malpica-Llanos, TM; McArthur, J; Nath, A; Sacktor, N | 1 |
| Herms, J; Kreth, FW; Mehrkens, JH; Pöpperl, G; Rachinger, W; Seelos, K; Tatsch, K; Tonn, JC | 1 |
| Cardiff, RD; Hardy, WR; Lam, SH; Muller, WJ; Pawson, T; Sanguin-Gendreau, V; Ursini-Siegel, J; Zuo, D | 1 |
| Barbieri, M; Crescenzi, B; D'Amico, M; Di Filippo, C; Ferraraccio, F; Laieta, MT; Marfella, R; Paolisso, G; Rossi, F; Sangiulo, P; Vestini, R | 1 |
| Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Sabel, M; Steiger, HJ; Stoffels, G | 1 |
| Chaitchik, S; Feldman, I; Fishman, P; Merimsky, O; Rapaport, Y; Shafir, R; Sheonfeld, Y | 1 |
| Hinton, DR; Hofman, FM; Incardonna, F; van der Veen, RC | 1 |
| Bankiewicz, KS; Eberling, JL; Jagust, WJ; Jordan, S; VanBrocklin, HF | 1 |
| Ambs, S; Bennett, WP; Billiar, TR; Felley-Bosco, E; Harris, CC; Klein, S; Merriam, WG; Ogunfusika, MO; Oser, SM; Shields, PG | 1 |
| Dykun, Y; Ronner, E; Simoons, ML; van den Brand, MJ; van der Wieken, LR | 1 |
| Carl, S; Kirchhoff, F; Mätz-Rensing, K; Sauermann, U; Sopper, S; Stahl-Hennig, C | 1 |
| Buchholz, J; Iacono, RP; Kuniyoshi, S; Liu, H; Schoonenberg, T | 1 |
| Berenguer, J; Berenguer, M; García-Herola, A; López-Viedma, B; Mir, J; Pascual, S; Prieto, M; Vilchez, JJ | 1 |
| Kolchinsky, A | 1 |
| Heikinheimo, M; Näntö-Salonen, K; Pitkänen, S; Salo, MK; Vettenranta, K | 1 |
| Bentz, BG; Haines, GK; Radosevich, JA | 1 |
| Band, H; Ikuno, Y; Kazlauskas, A; Klinghoffer, RA; Leong, FL; Miyake, S; Rosenkranz, S | 1 |
| Ahmed, B; Van Den Oord, JJ | 1 |
| Alexander, J; Barr, E; Ghannam, AF; Pharand, C; Sax, FL; Snapinn, S; Théroux, P | 1 |
| Bevilaqua, C; Britti, D; Caputi, AP; Costantino, G; Cuzzocrea, S; De Sarro, A; Mazzon, E; Mazzullo, G | 1 |
| Aliev, G; Atwood, CS; Balraj, EK; Chiba, S; Ghanbari, H; Hirai, K; Jones, PK; Nunomura, A; Perry, G; Petersen, RB; Shimohama, S; Smith, MA; Takeda, A; Wataya, T | 1 |
| Bocchi, EA; Cuoco, MA; da Silva, FF; Freitas, HF; Krieger, JE; Mansur, AJ; Mota, GF; Pereira, AC; Soler, JM | 1 |
| Buhmann, C; Oechsner, M; Strauss, J; Stuerenburg, HJ | 1 |
| Brown, AJ; Dean, RT; Kettle, AJ; Mashima, R; Niu, X; Senthilmohan, R; Stocker, R; Upston, JM; Wang, H | 1 |
| Ballinger, SW; Burow, DL; Hu, ZY; Ischiropoulos, H; Knight-Lozano, CA; Pinkerton, KE; Uyeminami, D; Young, CG | 1 |
| Arruda, P; Castro, GM; de Nucci, G; Langone, F; Martins, ML; Muscará, MN; Papes, F; Rogério, F; Santos, LM; Teixeira, SA | 1 |
| Arteaga, CL; Khuri, F; Krystal, G; Sebti, S | 1 |
7 review(s) available for tyrosine and Disease Exacerbation
| Article | Year |
|---|---|
Tyrosine phosphorylation of tumor cell caveolin-1: impact on cancer progression.
Topics: Animals; Caveolin 1; Cell Movement; Disease Progression; Focal Adhesions; Humans; Neoplasms; Phosphorylation; src-Family Kinases; Tyrosine | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.
Topics: Aldehydes; Alzheimer Disease; Brain; Disease Progression; Humans; Nerve Tissue Proteins; Oxidation-Reduction; Oxidative Stress; Tyrosine | 2011 |
Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.
Topics: Adaptor Proteins, Signal Transducing; Breast; Breast Neoplasms; Cell Movement; Disease Progression; DNA-Binding Proteins; Female; Hepatocyte Growth Factor; Humans; Mitogen-Activated Protein Kinase 7; Neoplasm Proteins; Phosphorylation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-met; RNA-Binding Proteins; Signal Transduction; Tyrosine | 2012 |
Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; Child; Child, Preschool; Disease Progression; Dopamine Agonists; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Male; Monoamine Oxidase Inhibitors; Prognosis; Sex Factors; Treatment Outcome; Tyrosine; Vitamin B 6 | 2004 |
Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Disease Progression; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Tyrosine | 1998 |
Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer.
Topics: Alkyl and Aryl Transferases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Transformation, Neoplastic; Clinical Trials as Topic; Disease Progression; Enzyme Inhibitors; ErbB Receptors; Farnesyltranstransferase; Humans; Lung Neoplasms; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Receptor Protein-Tyrosine Kinases; Research Design; Signal Transduction; Tyrosine; Up-Regulation | 2002 |
8 trial(s) available for tyrosine and Disease Exacerbation
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Nitration-mediated deficiency of cystathionine β-synthase activity accelerates the progression of hyperhomocysteinemia.
Topics: Adult; Aged; Aged, 80 and over; Animals; Cystathionine beta-Synthase; Disease Models, Animal; Disease Progression; Female; Free Radical Scavengers; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metalloporphyrins; Middle Aged; Mutation; Nitro Compounds; Nitrosative Stress; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tyrosine | 2017 |
Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.
Topics: Adult; Aged; Bevacizumab; Disease Progression; Drug Interactions; Female; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Treatment Outcome; Tyrosine | 2018 |
The treatment of multiple sclerosis with inosine.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Brain; CD4 Lymphocyte Count; Central Nervous System; Cross-Over Studies; Cytokines; Disability Evaluation; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Inosine; Kidney Calculi; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Th1 Cells; Th2 Cells; Tyrosine; Uric Acid; Young Adult | 2009 |
Treatment of progressive stroke with tirofiban--experience in 35 patients.
Topics: Aged; Arterial Occlusive Diseases; Disease Progression; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity.
Topics: Acetylcholine; Biopsy; Cell Nucleus; Diabetes Mellitus, Type 2; Disease Progression; Endothelium, Vascular; Enzyme Activation; Female; Forearm; Humans; Immunohistochemistry; Male; Microcirculation; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Poly(ADP-ribose) Polymerases; Polymorphism, Genetic; Predictive Value of Tests; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reference Values; Risk Assessment; Skin; Statistics as Topic; Tyrosine | 2002 |
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
Topics: Biomarkers; C-Reactive Protein; Cardiotonic Agents; Case-Control Studies; Cell Adhesion Molecules; Chemokine CCL2; Colorimetry; Cytokines; Dinoprost; Disease Progression; Dobutamine; E-Selectin; Enzyme-Linked Immunosorbent Assay; Exercise Test; Female; Heart Failure; Humans; Inflammation; Interleukin-18; Interleukin-6; Male; Middle Aged; Milrinone; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Tyrosine | 2006 |
Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Uns
Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Diabetes Complications; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heparin; Humans; Infusions, Intravenous; Likelihood Functions; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
161 other study(ies) available for tyrosine and Disease Exacerbation
| Article | Year |
|---|---|
Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor.
Topics: Animals; Disease Progression; Immune Checkpoint Inhibitors; Mice; Neoplasms; Tyrosine | 2022 |
Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
Topics: Amino Acids, Aromatic; Animals; Disease Progression; Gastrointestinal Microbiome; Glucuronides; Glutamine; Humans; Indoles; Mice; Myocardial Infarction; Tryptophan; Tyrosine | 2023 |
Topics: Adult; Aged; Disease Progression; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult | 2020 |
18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tyrosine | 2020 |
Treatment Monitoring of Immunotherapy and Targeted Therapy Using
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Female; Humans; Immunotherapy; Lung Neoplasms; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Retrospective Studies; Treatment Outcome; Tyrosine | 2021 |
Clinical Penetrance of Hereditary Hemochromatosis-Related End-Organ Damage of C282Y Homozygosity, A Newfoundland Experience.
Topics: Adult; Cysteine; Disease Progression; Female; Follow-Up Studies; Genetic Testing; Hemochromatosis; Hemochromatosis Protein; Hemosiderosis; Homozygote; Humans; Iron; Liver Cirrhosis; Male; Middle Aged; Newfoundland and Labrador; Penetrance; Retrospective Studies; Tyrosine | 2020 |
Mitochondria exert age-divergent effects on recovery from spinal cord injury.
Topics: 2,4-Dinitrophenol; Aging; Animals; Cell Survival; Disease Progression; Female; Mice; Mice, Inbred C57BL; Mitochondria; Neurodegenerative Diseases; Neurons; Oxidative Stress; Oxygen Consumption; Reactive Oxygen Species; Recovery of Function; Spinal Cord Injuries; Tyrosine; Uncoupling Agents | 2021 |
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Temozolomide; Tyrosine | 2021 |
Oxidative stress parameters as biomarkers of bladder cancer development and progression.
Topics: Adult; Antioxidants; Biomarkers; Case-Control Studies; Disease Progression; Female; Free Radicals; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Sulfhydryl Compounds; Tyrosine; Urinary Bladder Neoplasms | 2021 |
Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[
Topics: alpha-Synuclein; Animals; Dependovirus; Disease Models, Animal; Disease Progression; Dopaminergic Neurons; Fluorine Radioisotopes; Male; Motor Activity; Parkinson Disease; Phosphorylation; Positron-Emission Tomography; Protein Aggregates; Rats, Sprague-Dawley; Synucleinopathies; Tyrosine | 2021 |
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.
Topics: Adult; Age Factors; Amino Acids; Biomarkers; Case-Control Studies; Disease Progression; Female; Glutamic Acid; Humans; Insulin Resistance; Isoleucine; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Tyrosine | 2018 |
The profiling of plasma free amino acids and the relationship between serum albumin and plasma-branched chain amino acids in chronic liver disease: a single-center retrospective study.
Topics: Adult; Aged; Amino Acids, Branched-Chain; Chronic Disease; Disease Progression; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Serum Albumin; Severity of Illness Index; Tyrosine | 2018 |
Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Blood Urea Nitrogen; Creatinine; Diet, Fat-Restricted; Diet, High-Fat; Dietary Fats; Disease Models, Animal; Disease Progression; Kidney Failure, Chronic; Kidney Function Tests; Lipids; Lipoproteins; Macrophages; Male; Mice; Mice, Knockout; Muscle Proteins; Nephrectomy; Oxidants; Oxidative Stress; Parathyroid Hormone; Peroxidase; Receptors, LDL; Tyrosine; Vasodilation | 2018 |
Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma.
Topics: Aged; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2018 |
Phosphorylation of different tau sites during progression of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Female; Humans; Male; Middle Aged; Phosphorylation; Psychiatric Status Rating Scales; Serine; Statistics, Nonparametric; tau Proteins; Threonine; Tyrosine | 2018 |
Plasma Nuclear Magnetic Resonance Metabolomics Discriminates Between High and Low Endoscopic Activity and Predicts Progression in a Prospective Cohort of Patients With Ulcerative Colitis.
Topics: Adolescent; Adult; Amino Acids; Blood Glucose; Colitis, Ulcerative; Disease Progression; Endoscopy, Gastrointestinal; Female; Histidine; Humans; Isoleucine; Lipoproteins; Lysine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Phenylalanine; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Single-Blind Method; Tyrosine; Valine; Young Adult | 2018 |
A father's fight to help his sons - and fix clinical trials.
Topics: Adolescent; Alkaptonuria; Animals; Autopsy; Child; Clinical Trials as Topic; Compassionate Use Trials; Cyclohexanones; Disease Models, Animal; Disease Progression; Drug Approval; Endpoint Determination; Female; Homogentisic Acid; Humans; Infant; Male; Mice; National Health Programs; National Institutes of Health (U.S.); Nitrobenzoates; Observational Studies as Topic; Off-Label Use; Orphan Drug Production; Rare Diseases; Rats; Sample Size; Tyrosine; Tyrosinemias; United States; United States Food and Drug Administration | 2019 |
The Potential Role of Neutrophil Gelatinase-Associated Lipocalin in the Development of Abdominal Aortic Aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Apoptosis; Biomarkers; Caspase 3; Dilatation, Pathologic; Disease Progression; Female; Humans; Lipocalin-2; Male; Matrix Metalloproteinase 9; Middle Aged; Oxidative Stress; Retrospective Studies; Tyrosine; Up-Regulation; Vascular Remodeling | 2019 |
Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; HEK293 Cells; Humans; Kinetics; Mice; Mice, Nude; Models, Molecular; NADP; Neoplasms; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Phosphorylation; Radiation, Ionizing; Reactive Oxygen Species; Ribosemonophosphates; Tyrosine; Up-Regulation | 2019 |
Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson's Disease Patients.
Topics: Adult; Aged; Biogenic Amines; Biomarkers; Cross-Sectional Studies; Disease Progression; Early Diagnosis; Female; Humans; Male; Middle Aged; Norepinephrine; Parkinson Disease; Serotonin; Synephrine; Tyramine; Tyrosine | 2019 |
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI.
Topics: Adult; Aged; Aged, 80 and over; Diffusion; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Tyrosine; Young Adult | 2019 |
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Tyrosine; Young Adult | 2019 |
The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis.
Topics: Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Bone Morphogenetic Protein Receptors, Type II; Carotid Stenosis; Chemokine CCL2; DEAD-box RNA Helicases; Disease Progression; Gene Expression Regulation; Interleukin-6; Macrophage Activation; Macrophages; Mice; Mice, Knockout; MicroRNAs; Nitric Oxide Synthase Type II; Oligonucleotides; Proto-Oncogene Proteins c-akt; Ribonuclease III; RNA, Antisense; Signal Transduction; Tyrosine; Up-Regulation; Vasculitis | 2013 |
The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis.
Topics: Administration, Oral; Amyotrophic Lateral Sclerosis; Animals; Axons; Dietary Supplements; Disease Models, Animal; Disease Progression; Eicosapentaenoic Acid; Female; Humans; Lipid Metabolism; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Motor Neurons; Mutant Proteins; Neuroglia; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Survival Analysis; Tyrosine; Vacuoles | 2013 |
NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.
Topics: Amyotrophic Lateral Sclerosis; Animals; Axonal Transport; Blotting, Western; Body Weight; Brain; Contrast Media; Disease Progression; Female; Magnetic Resonance Imaging; Male; Manganese; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Neuroprotective Agents; Oligopeptides; Phosphorylation; Psychomotor Performance; Spinal Cord; tau Proteins; Tubulin; Tyrosine; Ventral Tegmental Area | 2013 |
Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.
Topics: Animals; Antioxidants; Chronic Disease; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidases; Oxidative Stress; Pulmonary Artery; Reactive Oxygen Species; Scavenger Receptors, Class E; Signal Transduction; Tyrosine; Up-Regulation; Ventricular Function, Right; Ventricular Pressure | 2013 |
Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma.
Topics: Adolescent; Adult; Biological Transport; Child; Disease Progression; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Regression Analysis; Tyrosine; Young Adult | 2013 |
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.
Topics: Adult; Astrocytes; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk; Time Factors; Treatment Outcome; Tyrosine | 2014 |
Role of energy metabolic deficits and oxidative stress in excitotoxic spinal motor neuron degeneration in vivo.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antioxidants; Cell Death; Disease Models, Animal; Disease Progression; Lumbar Vertebrae; Male; Motor Activity; Motor Neurons; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Paralysis; Rats; Rats, Wistar; Reactive Oxygen Species; Tyrosine | 2014 |
A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tyrosine | 2014 |
Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.
Topics: Animals; Autocrine Communication; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; Endothelial Cells; Female; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neoplasm Grading; Neovascularization, Pathologic; Phosphorylation; Profilins; RNA Interference; Time Factors; Transfection; Tumor Burden; Tumor Microenvironment; Tyrosine; Up-Regulation; Von Hippel-Lindau Tumor Suppressor Protein | 2014 |
Role of oxidative stress-induced systemic and cavernosal molecular alterations in the progression of diabetic erectile dysfunction.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Disease Progression; Endothelium, Vascular; Erectile Dysfunction; Fluorescent Antibody Technique; Immunoblotting; Male; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Oxidative Stress; Penis; Rats; Rats, Wistar; Tyrosine | 2015 |
Prediction of glioma recurrence using dynamic ¹⁸F-fluoroethyltyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tyrosine | 2014 |
Effects of topically applied tocotrienol on cataractogenesis and lens redox status in galactosemic rats.
Topics: Administration, Topical; Animals; Anterior Eye Segment; Catalase; Cataract; Disease Progression; Emulsions; Eye Proteins; Galactosemias; Glutathione; Lens, Crystalline; Liposomes; Malondialdehyde; Nitric Oxide Synthase Type II; Oxidation-Reduction; Particle Size; Rats; Rats, Sprague-Dawley; Static Electricity; Stress, Physiological; Superoxide Dismutase; Tocotrienols; Tyrosine; Viscosity | 2014 |
Comparison of nasal nitric oxide levels between the inferior turbinate surface and the middle meatus in patients with symptomatic allergic rhinitis.
Topics: Adult; Biomarkers; Breath Tests; Disease Progression; Eosinophil Cationic Protein; Eosinophils; Exhalation; Female; Humans; Male; Nasal Cavity; Nitric Oxide; Rhinitis, Allergic; Turbinates; Tyrosine | 2014 |
Oxidative stress and antioxidant status in patients with autoimmune liver diseases.
Topics: Adult; Aged; Aldehydes; Antioxidants; Autoimmune Diseases; Carbon; Catalase; Disease Progression; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hepatitis, Autoimmune; Humans; Isoprostanes; Liver Diseases; Male; Middle Aged; Oxidative Stress; Peroxidase; Superoxide Dismutase; Tyrosine | 2015 |
M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice.
Topics: Animals; Cytochrome P-450 CYP2E1; Disease Progression; Gene Expression Regulation; Lipid Peroxidation; Liver; Macrophages; Male; Mice; Mice, Obese; Nitric Oxide Donors; Nitroso Compounds; Non-alcoholic Fatty Liver Disease; Oxidative Stress; RNA, Messenger; Tyrosine | 2015 |
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; False Positive Reactions; Female; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2015 |
The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tyrosine | 2015 |
Inducible and endothelial nitric synthetase expression and nitrotyrosine accumulation in iris vasculature of patients with primary open-angle glaucoma: a pilot study.
Topics: Aged; Disease Progression; Female; Gene Expression Regulation, Enzymologic; Glaucoma, Open-Angle; Humans; Iris; Male; Manometry; Middle Aged; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenotype; Pilot Projects; Predictive Value of Tests; Tyrosine; Up-Regulation | 2015 |
Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis.
Topics: Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Progression; DNA; DNA Mismatch Repair; ErbB Receptors; Genome; Genome, Human; HeLa Cells; Humans; Microscopy, Fluorescence; Models, Molecular; Mutation; Neoplasms; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Binding; Sequence Analysis, DNA; Tyrosine | 2015 |
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion.
Topics: Active Transport, Cell Nucleus; Amides; Animals; Apoptosis; Cell Nucleus; Chymases; Cytokines; Disease Models, Animal; Disease Progression; Drug Interactions; Ethanolamines; Gene Expression Regulation; Kidney; Male; Mice; Nitrates; Nitrites; Oxidative Stress; Palmitic Acids; Reperfusion Injury; Risk Factors; Silymarin; Transcription Factor RelA; Tyrosine | 2015 |
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.
Topics: Brain Neoplasms; Disease Progression; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tyrosine | 2015 |
Oxidative/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain.
Topics: Aldehydes; Animals; Body Weight; Chemokine CCL2; Connective Tissue Growth Factor; Disease Progression; Disease Resistance; Dose-Response Relationship, Drug; Doxorubicin; Fibrosis; Kidney; Male; Membrane Proteins; Oxidative Stress; Proteinuria; Rats; Reactive Nitrogen Species; Species Specificity; Transforming Growth Factor beta1; Tyrosine | 2015 |
A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK.
Topics: Adenine; Adult; Aged; Amyloid Neuropathies, Familial; Cohort Studies; Disease Progression; DNA Mutational Analysis; Female; Genes, Dominant; Humans; Male; Middle Aged; Mutation, Missense; Neural Conduction; Neurologic Examination; Peripheral Nervous System Diseases; Phenotype; Prealbumin; Retrospective Studies; Tyrosine | 2016 |
Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Autoantibodies; Biomarkers; Deglutition Disorders; Disease Progression; Drug Administration Schedule; Female; Glucocorticoids; Humans; Middle Aged; Myasthenia Gravis; Prednisolone; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Outcome; Tyrosine | 2015 |
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult | 2016 |
Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study.
Topics: Adolescent; Adult; Aged; Disease Progression; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tumor Burden; Tyrosine; Young Adult | 2016 |
Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products.
Topics: Aged; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Glycation End Products, Advanced; Humans; Male; Middle Aged; Prediabetic State; Severity of Illness Index; Tyrosine | 2017 |
Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Tyrosine; Young Adult | 2017 |
Phosphorylation of H2A.X
Topics: Amino Acid Sequence; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Comet Assay; Disease Progression; DNA Breaks, Double-Stranded; DNA Repair; Hep G2 Cells; Histones; Humans; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Mutation; Neoplasms; Nuclear Proteins; Phosphorylation; Protein Tyrosine Phosphatases; RNA Interference; Sequence Homology, Amino Acid; Tyrosine | 2016 |
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
Topics: Adult; Aged; Brain Neoplasms; Cluster Analysis; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Pilot Projects; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome; Tyrosine; Unsupervised Machine Learning | 2017 |
Patterns of failure for patients with glioblastoma following O-(2-[
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy, Image-Guided; Retrospective Studies; Treatment Failure; Tyrosine | 2017 |
Oxidative modifications of blood serum proteins in myasthenia gravis.
Topics: Adult; Advanced Oxidation Protein Products; Aged; Aged, 80 and over; Autoantibodies; Benzothiazoles; Blood Proteins; Disease Progression; Female; Glycophorins; Humans; Kynurenine; Male; Middle Aged; Myasthenia Gravis; Oxidative Stress; Protein Carbonylation; Receptors, Cholinergic; Sulfonic Acids; Thymectomy; Tyrosine | 2017 |
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression.
Topics: Adult; Aged; Aged, 80 and over; Arginase; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Italy; Lung Neoplasms; Male; Microscopy, Confocal; Middle Aged; Neoplasm Staging; Nitric Oxide Synthase; Nitrites; Peroxynitrous Acid; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Tyrosine | 2008 |
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
Topics: Cell Line, Tumor; Disease Progression; ErbB Receptors; Female; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Neoplasm Invasiveness; Ovarian Neoplasms; Paxillin; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Tyrosine | 2008 |
Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Biomarkers; Blood Glucose; Body Weight; Deoxyguanosine; Diabetic Nephropathies; Disease Progression; Glycated Hemoglobin; Immunohistochemistry; Male; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Taurine; Tyrosine | 2008 |
A key tyrosine (Y1494) in the beta4 integrin regulates multiple signaling pathways important for tumor development and progression.
Topics: Breast Neoplasms; Cell Line, Tumor; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Humans; Immunohistochemistry; Integrin alpha6beta4; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Signal Transduction; src-Family Kinases; Tyrosine | 2008 |
Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression.
Topics: Biomarkers, Tumor; Breast Neoplasms; Disease Progression; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neuregulin-1; Phosphorylation; Prognosis; Protein Phosphatase 2; Protein-Tyrosine Kinases; Receptor, ErbB-2; Signal Transduction; Tissue Array Analysis; Tumor Cells, Cultured; Tyrosine | 2009 |
Increased production and secretion of HGF alpha-chain and an antagonistic HGF fragment in a human breast cancer progression model.
Topics: Blotting, Western; Breast Neoplasms; Cell Transformation, Neoplastic; Culture Media, Conditioned; Disease Progression; Genes, ras; Hepatocyte Growth Factor; Humans; Mesoderm; Neoplasm Invasiveness; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-met; Tyrosine | 2009 |
Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice.
Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antioxidants; Apoptosis; Collagen; Disease Models, Animal; Disease Progression; Fibrosis; Glucosephosphate Dehydrogenase; HSP47 Heat-Shock Proteins; Hydrogen Peroxide; Ischemia; Kidney; Lipid Peroxidation; Male; Metalloporphyrins; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxidative Stress; Proliferating Cell Nuclear Antigen; Reactive Oxygen Species; Reperfusion Injury; S100 Calcium-Binding Protein A4; S100 Proteins; Superoxide Dismutase; Time Factors; Tyrosine; Vitamin E | 2009 |
The prognostic role of phospho-Src family kinase analysis in tongue cancer.
Topics: Aged; Biomarkers, Tumor; Disease Progression; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Phosphoproteins; Phosphorylation; Prognosis; Receptor, ErbB-2; src-Family Kinases; Tongue Neoplasms; Tyrosine | 2010 |
Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients.
Topics: Aged; Amino Acid Transport System L; Analysis of Variance; Critical Illness; Delirium; Disease Progression; Female; Humans; Logistic Models; Male; Markov Chains; Middle Aged; Phenylalanine; Pilot Projects; Predictive Value of Tests; Regression Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Tennessee; Time Factors; Tryptophan; Tyrosine | 2009 |
Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Animals; Catalytic Domain; Central Nervous System; Disease Models, Animal; Disease Progression; Facial Nerve; Gene Expression Regulation; Hepatocyte Growth Factor; Humans; Mice; Mice, Transgenic; Motor Neurons; Phosphorylation; Protein Phosphatase 2; Proto-Oncogene Proteins c-met; Rhombencephalon; Serine; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine | 2009 |
Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Barrett Esophagus; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 2; Disease Progression; Esophageal Neoplasms; Esophagus; Female; Gastroesophageal Reflux; Glutathione S-Transferase pi; Humans; Immunohistochemistry; Iran; Male; Middle Aged; Precancerous Conditions; Tumor Suppressor Protein p53; Tyrosine; Young Adult | 2009 |
Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN.
Topics: Animals; Aortic Aneurysm, Abdominal; Basigin; Disease Progression; Down-Regulation; Endothelium, Vascular; Enzyme Induction; Extracellular Space; Humans; Matrix Metalloproteinase 13; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Tyrosine | 2009 |
Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis.
Topics: Aconitate Hydratase; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Detergents; Disease Models, Animal; Disease Progression; Electrophoresis, Gel, Two-Dimensional; Humans; Immunohistochemistry; Mice; NG-Nitroarginine Methyl Ester; Protein Structure, Quaternary; Proteins; Proteomics; Reproducibility of Results; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spinal Cord; Stress, Physiological; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine | 2009 |
Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression.
Topics: Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cell Movement; Child, Preschool; Disease Progression; Female; Humans; Immunohistochemistry; Infant; Infant, Newborn; Male; Matrix Metalloproteinase 14; Microscopy, Confocal; Neuroblastoma; Phosphorylation; Tissue Array Analysis; Tyrosine | 2009 |
Oxidative stress in the progression of Alzheimer disease in the frontal cortex.
Topics: Aged; Aged, 80 and over; Aldehydes; Alzheimer Disease; Antioxidants; Biomarkers; Disease Progression; Female; Frontal Lobe; Humans; Male; Mental Status Schedule; Oxidative Stress; Protein Carbonylation; Synapses; Thiobarbituric Acid Reactive Substances; Tissue Distribution; Tyrosine | 2010 |
Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.
Topics: Adult; Aged; Biomarkers; Disease Progression; Female; Health Status; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Severity of Illness Index; Superoxide Dismutase; Tyrosine; Young Adult | 2010 |
Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.
Topics: Animals; Breast Neoplasms; Cell Membrane; Disease Progression; Female; Humans; Male; Mice; Mice, Transgenic; Phosphorylation; Prostatic Intraepithelial Neoplasia; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Tyrosine | 2010 |
Insulin and IGF-1 receptors, nitrotyrosin and cerebral neuronal deficits in two young patients with diabetic ketoacidosis and fatal brain edema.
Topics: Adolescent; Biomarkers; Brain Edema; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Disease Progression; Fatal Outcome; Female; Humans; Insulin; Receptor, IGF Type 1; Tyrosine | 2010 |
Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model.
Topics: Administration, Inhalation; Aldehydes; Animals; Antioxidants; Aquaporin 4; Brain Damage, Chronic; Cerebral Hemorrhage; Disease Progression; Drug Evaluation, Preclinical; Extracellular Matrix Proteins; Glucose; Hydrogen; Hyperglycemia; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Tyrosine | 2010 |
Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability.
Topics: Aged; Aged, 80 and over; Biomarkers; Blotting, Western; Carotid Artery, Internal; Carotid Stenosis; Case-Control Studies; Disease Progression; Endarterectomy, Carotid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Lipoproteins, LDL; Male; Malondialdehyde; Matrix Metalloproteinase 9; Middle Aged; Oxidative Stress; Prospective Studies; Protein Carbonylation; Rupture; Severity of Illness Index; Tyrosine; Up-Regulation | 2010 |
Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Disease Progression; Fluorescent Antibody Technique; Humans; Mice; Mice, Transgenic; Microscopy, Confocal; Microscopy, Immunoelectron; Phosphorylation; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-fyn; src-Family Kinases; tau Proteins; Tauopathies; Tyrosine | 2010 |
A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration.
Topics: Asparagine; Brain; Disease Progression; DNA Mutational Analysis; Family Health; Female; Frontotemporal Dementia; Gerstmann-Straussler-Scheinker Disease; Humans; Middle Aged; Neurofibrillary Tangles; Prion Proteins; Prions; Tyrosine; Ubiquitin; Voltage-Dependent Anion Channels | 2010 |
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
Topics: Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Cystic Fibrosis; Disease Progression; Female; Humans; Infant; Inflammation; Male; Neutrophils; Oxidation-Reduction; Peroxidase; Pseudomonas aeruginosa; Respiratory Tract Infections; Tyrosine | 2010 |
Inhibition of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Biotin; Caspases; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Matrix Metalloproteinase 14; Mice; Molecular Sequence Data; Peptides; Phosphorylation; Sarcoma, Experimental; Tyrosine; Xenograft Model Antitumor Assays | 2010 |
Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers.
Topics: Animals; Blood Glucose; Blood Pressure; Cells, Cultured; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Humans; Kidney Glomerulus; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; NADPH Oxidase 4; NADPH Oxidases; Nicotine; Nicotinic Agonists; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Smoking; Tyrosine | 2010 |
A novel SOD1 mutation in a young amyotrophic lateral sclerosis patient with a very slowly progressive clinical course.
Topics: Adult; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Disease Progression; Electromyography; Humans; Leg; Male; Muscle Weakness; Muscle, Skeletal; Mutation; Peripheral Nerves; Phenotype; Superoxide Dismutase; Superoxide Dismutase-1; Time Factors; Tyrosine | 2010 |
DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway.
Topics: Amino Acid Motifs; CD4-Positive T-Lymphocytes; Cells, Cultured; Disease Progression; HIV Infections; HIV-1; Humans; Lectins, C-Type; Membrane Glycoproteins; Phosphorylation; Protein Binding; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Protein Kinases; Receptors, Immunologic; Signal Transduction; Tyrosine; Up-Regulation | 2011 |
Elevated NRD1 metalloprotease expression plays a role in breast cancer growth and proliferation.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Disease Progression; Epidermal Growth Factor; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunohistochemistry; Metalloproteases; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Tyrosine; Up-Regulation | 2011 |
[Role of mitochondria and reactive oxygen species in the progression of heart failure].
Topics: Adult; Case-Control Studies; Disease Progression; Female; Heart Failure; Humans; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Mitochondria, Heart; Nitric Oxide Synthase Type II; Reactive Oxygen Species; Severity of Illness Index; Tyrosine | 2010 |
Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.
Topics: Antigens, CD; Antigens, Neoplasm; Binding Sites; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Membrane; Disease Progression; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Gene Silencing; HeLa Cells; Humans; Microscopy, Confocal; Neoplasm Proteins; Phosphorylation; src-Family Kinases; Tyrosine | 2011 |
Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease.
Topics: Airway Remodeling; Animals; Dinoprost; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Guinea Pigs; Hypertension, Pulmonary; Inflammation; Lung; Oxidative Stress; Peroxidase; Pulmonary Disease, Chronic Obstructive; Purines; Smoking; Thiones; Thioxanthenes; Tyrosine | 2012 |
Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis.
Topics: Adult; Blood Proteins; Blood-Brain Barrier; Carbon; Disease Progression; Female; Humans; Male; Middle Aged; Models, Statistical; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress; Oxygen; Reactive Oxygen Species; Tyrosine; Uric Acid | 2012 |
Relationship between 3-O-methyldopa and the clinical effects of entacapone in advanced Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Biomarkers; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Disease Progression; Dopa Decarboxylase; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Japan; Levodopa; Male; Middle Aged; Motor Activity; Nitriles; Parkinson Disease; Prospective Studies; Treatment Outcome; Tyrosine | 2011 |
Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stress.
Topics: Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Hyperglycemia; Hyperinsulinism; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Superoxides; Time Factors; Tyrosine | 2012 |
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Contrast Media; Disease Progression; Disease-Free Survival; Female; Gadolinium; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tyrosine | 2012 |
Role of peroxynitrite-modified H2A histone in the induction and progression of rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Autoantibodies; C-Reactive Protein; Disease Progression; Histones; Humans; Immunoglobulin G; Peroxynitrous Acid; Rheumatoid Factor; Tyrosine | 2012 |
Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease.
Topics: Animals; Arterial Pressure; Cell Hypoxia; Creatinine; Cyclic N-Oxides; Disease Progression; Glucose Transporter Type 1; Heme Oxygenase (Decyclizing); Hemodynamics; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Kidney Diseases; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Polycystic Kidney Diseases; Rats; Rats, Inbred Lew; Spin Labels; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine; Vascular Endothelial Growth Factor A | 2012 |
Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Encephalitis; Fluoresceins; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; NADPH Oxidases; Neuroglia; Neuroprotective Agents; Neurotransmitter Agents; Nitric Oxide Synthase Type II; Organic Chemicals; Tyrosine; Tyrosine 3-Monooxygenase | 2012 |
A plasma oxidative stress global index in early stages of chronic venous insufficiency.
Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Catalase; Chronic Disease; Disease Progression; Early Diagnosis; Female; Glutathione; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peroxidase; Predictive Value of Tests; Protein Carbonylation; Sulfhydryl Compounds; Tyrosine; Ultrasonography, Doppler, Color; Uric Acid; Veins; Venous Insufficiency; Xanthine Oxidase | 2013 |
Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model.
Topics: Analgesics; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Division; Disease Models, Animal; Disease Progression; ErbB Receptors; Female; Isoflavones; Mice; Mice, Inbred ICR; Mice, Nude; Mitotic Index; Neoplasm Metastasis; Osteoclasts; Phosphorylation; Treatment Outcome; Tyrosine | 2002 |
Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia.
Topics: Afferent Pathways; Anesthetics, Local; Animals; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Freund's Adjuvant; GTP-Binding Proteins; Hindlimb; Hyperalgesia; Inflammation; Male; Pain Measurement; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Spinal Cord; src-Family Kinases; Tyrosine | 2002 |
PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy.
Topics: Adaptation, Physiological; Animals; Cardiac Output, Low; Disease Progression; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Focal Adhesion Protein-Tyrosine Kinases; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tyrosine | 2002 |
Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bulgaria; Chromatography, High Pressure Liquid; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Nerve Growth Factors; Predictive Value of Tests; Prognosis; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tyrosine | 2002 |
Mitochondrial integrity and function in atherogenesis.
Topics: Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Disease Models, Animal; Disease Progression; DNA Damage; DNA, Mitochondrial; Heterozygote; Homozygote; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Phenotype; Reactive Oxygen Species; Superoxide Dismutase; Tyrosine | 2002 |
Distinct renal injury in early atherosclerosis and renovascular disease.
Topics: Animals; Antioxidants; Arteriosclerosis; Cholesterol, Dietary; Disease Models, Animal; Disease Progression; Glomerular Filtration Rate; Hemodynamics; Hypercholesterolemia; Hypertension; Immunohistochemistry; Kidney; Kidney Function Tests; Kidney Tubules; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidation-Reduction; Regional Blood Flow; Renal Artery Obstruction; Swine; Tomography, X-Ray Computed; Tyrosine; Vasodilator Agents | 2002 |
Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.
Topics: Animals; Disease Progression; Drug Administration Schedule; Galactose; Galactosemias; Glutathione; Hexoses; Lipid Peroxides; Male; Metabolic Diseases; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Protein Kinase C; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Tyrosine | 2002 |
The nitroxide antioxidant tempol is cerebroprotective against focal cerebral ischemia in spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Brain Ischemia; Cyclic N-Oxides; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Infarction, Middle Cerebral Artery; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Rats; Rats, Inbred SHR; Spin Labels; Treatment Outcome; Tyrosine | 2002 |
Natural history of alkaptonuria.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Alkaptonuria; Child; Child, Preschool; Connective Tissue Diseases; Cyclohexanones; Dioxygenases; Disease Progression; DNA Mutational Analysis; Enzyme Inhibitors; Female; Heart Valve Diseases; Homogentisate 1,2-Dioxygenase; Humans; Joint Diseases; Kidney Calculi; Life Tables; Linear Models; Longitudinal Studies; Male; Middle Aged; Mutation; Nitrobenzoates; Oxygenases; Severity of Illness Index; Tyrosine | 2002 |
Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps.
Topics: Acute Disease; Administration, Oral; Adoptive Transfer; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Line; Cell Movement; Chronic Disease; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Growth Inhibitors; Immunosuppressive Agents; Injections, Intraperitoneal; Lymphocyte Activation; Mice; Mice, Inbred Strains; Microglia; Myelin Basic Protein; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylacetates; Phenylbutyrates; Severity of Illness Index; Spinal Cord; T-Lymphocyte Subsets; Transcription Factor RelA; Tyrosine | 2003 |
Endothelin-1 decreases gap junctional intercellular communication by inducing phosphorylation of connexin 43 in human ovarian carcinoma cells.
Topics: Animals; Cell Division; Cell Line, Tumor; Connexin 43; Disease Progression; Endothelin-1; Female; Humans; Immunoblotting; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Phosphorylation; Precipitin Tests; Time Factors; Tyrosine | 2003 |
A Tyr368His RPE65 founder mutation is associated with variable expression and progression of early onset retinal dystrophy in 10 families of a genetically isolated population.
Topics: Amino Acid Substitution; Carrier Proteins; cis-trans-Isomerases; Disease Progression; DNA; DNA Mutational Analysis; Eye Proteins; Family Health; Female; Founder Effect; Genetic Variation; Heterozygote; Histidine; Homozygote; Humans; Male; Mutation; Netherlands; Pedigree; Proteins; Retinal Degeneration; Tyrosine | 2003 |
Suppression of cell migration in ovarian cancer cells mediated by PTEN overexpression.
Topics: Animals; Blotting, Western; Calcium Phosphates; Cell Line, Tumor; Cell Movement; Cloning, Molecular; Disease Progression; DNA, Complementary; Female; Gene Library; Humans; Kinetics; Liver; Mice; Mice, Inbred BALB C; Ovarian Neoplasms; Phosphoric Monoester Hydrolases; Phosphorylation; Plasmids; Prognosis; PTEN Phosphohydrolase; Time Factors; Transfection; Tumor Suppressor Proteins; Tyrosine; Wound Healing | 2003 |
Cardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues.
Topics: Adult; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cardiomyopathy, Dilated; Disease Progression; Echocardiography; Female; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Inbred C57BL; Microscopy, Electron; Murine Acquired Immunodeficiency Syndrome; Myocardium; Reactive Nitrogen Species; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; T-Lymphocytes; Tyrosine | 2003 |
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway.
Topics: Animals; Blotting, Northern; Carcinoma, Papillary; Cell Line; Chromatography, High Pressure Liquid; Culture Media, Conditioned; Cyclooxygenase 2; Dinoprostone; Disease Progression; Dose-Response Relationship, Drug; Eicosanoids; Gene Library; Humans; Hydroxyeicosatetraenoic Acids; Intramolecular Oxidoreductases; Isoenzymes; Membrane Proteins; Mutation; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Rats; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Thyroid Neoplasms; Time Factors; Transcription, Genetic; Transcriptional Activation; Tyrosine; Up-Regulation | 2003 |
Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface.
Topics: Aldosterone; Animals; Calcium; Cell Separation; Coronary Vessels; Disease Models, Animal; Disease Progression; Gene Expression Profiling; Gene Expression Regulation; Genes, MHC Class II; Hydrogen Peroxide; Hyperaldosteronism; Leukocytes, Mononuclear; Lymphocyte Activation; Magnesium; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Nephrectomy; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spironolactone; Tyrosine | 2003 |
Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antibodies, Monoclonal; Blood Cells; CD18 Antigens; Cell Line, Tumor; Complement System Proteins; Cytotoxicity, Immunologic; Deoxyguanosine; Disease Progression; Drug Administration Schedule; Fibrosarcoma; Granulocytes; Immunohistochemistry; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neutrophil Infiltration; Neutrophils; Phenotype; Time Factors; Tyrosine | 2003 |
Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; CD11 Antigens; Cell Movement; Disease Models, Animal; Disease Progression; Female; Integrin alpha Chains; Lipid Peroxidation; Macrophages; Neutrophil Infiltration; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Proteins; Rats; Rats, Wistar; Spinal Cord Injuries; Thiobarbituric Acid Reactive Substances; Tyrosine | 2004 |
The Trypanosoma brucei cyclin, CYC2, is required for cell cycle progression through G1 phase and for maintenance of procyclic form cell morphology.
Topics: Animals; Cell Cycle; Cell Differentiation; Cell Nucleus; Cyclins; Disease Progression; DNA; DNA, Kinetoplast; Flow Cytometry; G1 Phase; Immunoblotting; Microtubules; Phenotype; Protozoan Proteins; RNA Interference; RNA, Messenger; Time Factors; Transfection; Tubulin; Tyrosine; Zinc Fingers | 2004 |
Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
Topics: Adaptor Proteins, Signal Transducing; Adenoma; Adenomatous Polyposis Coli Protein; Alleles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Clathrin; Colorectal Neoplasms; Cyclooxygenase 2; Dinoprostone; Disease Progression; Enterocytes; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Genes, APC; HeLa Cells; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Intestinal Mucosa; Intestine, Small; Isoenzymes; Jurkat Cells; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Mutation; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Recurrence; Signal Transduction; src-Family Kinases; Tissue Distribution; Transcriptional Activation; Tyrosine; Ubiquitin; Up-Regulation; Vanadates | 2004 |
17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Topics: Animals; Breast Neoplasms; Cell Line; Chlorocebus aethiops; Disease Progression; Estradiol; Humans; Hyperplasia; Male; Mice; Mitochondria; Neoplasm Metastasis; Oxidoreductases; Phosphorylation; Prostatic Neoplasms; Protein Binding; Protein Transport; Receptors, Androgen; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Tyrosine; Up-Regulation; WW Domain-Containing Oxidoreductase | 2005 |
Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Administration, Oral; Amyotrophic Lateral Sclerosis; Animals; Cell Count; Disease Models, Animal; Disease Progression; Gliosis; Lumbosacral Region; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pioglitazone; PPAR gamma; Psychomotor Performance; Spinal Cord; Superoxide Dismutase; Survival Rate; Thiazolidinediones; Tyrosine; Weight Loss | 2005 |
Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function.
Topics: Aged; Antioxidants; Ascorbic Acid; Cartilage, Articular; Cell Division; Cells, Cultured; Cellular Senescence; Chondrocytes; Disease Progression; DNA Replication; Female; Free Radicals; Genomic Instability; Glycosaminoglycans; Humans; Middle Aged; Organ Culture Techniques; Osteoarthritis, Knee; Oxidative Stress; Reactive Oxygen Species; Telomere; Tyrosine | 2005 |
Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Adenosquamous; Carcinoma, Ductal; Carcinoma, Squamous Cell; Cell Differentiation; Disease Progression; Female; Gene Expression Profiling; Mammary Neoplasms, Experimental; Mice; Oxazoles; PPAR delta; PPAR gamma; Thiazoles; Tyrosine | 2005 |
Response of metastatic recurrent neuroblastoma to nitisinone: a modulator of tyrosine metabolism.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Cyclohexanones; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Fatal Outcome; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Nitrobenzoates; Remission Induction; Treatment Outcome; Tyrosine | 2006 |
Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression.
Topics: Animals; Cell Movement; Cell Proliferation; Disease Progression; Female; Fibrosarcoma; Gelatin Sponge, Absorbable; Guanidine; Guanine; Inflammation; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Nitric Oxide Synthase Type II; Oxidation-Reduction; Reactive Nitrogen Species; Tyrosine | 2006 |
Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Animals, Newborn; Astrocytes; Brain; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cells, Cultured; Disease Progression; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; Fluorescent Antibody Technique, Indirect; Genetic Vectors; HeLa Cells; Humans; Immunoprecipitation; Microscopy, Fluorescence; Molecular Sequence Data; Neoplasm Proteins; Neoplasms; Peptides; Phosphoproteins; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; RNA Interference; RNA-Binding Proteins; Sequence Homology, Amino Acid; Signal Transduction; Tyrosine | 2005 |
Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Collagen; Disease Progression; Macrophages; Mice; Mice, Knockout; Monocytes; Placebos; Polyamines; Sevelamer; Tyrosine; Uremia | 2005 |
NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits.
Topics: Animals; Disease Progression; Endothelium; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Microcirculation; Models, Biological; NADPH Oxidases; Neutrophils; Oxidative Stress; Peroxidase; Reperfusion Injury; Tyrosine; Xanthine Oxidase | 2006 |
Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.
Topics: Adolescent; Child; Child, Preschool; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Heptanoates; Humans; Infant; Kidney; Kidney Glomerulus; Kidney Tubules; Liver Transplantation; Male; Time Factors; Tyrosine; Tyrosinemias | 2005 |
Normal and prostate cancer cells display distinct molecular profiles of alpha-tubulin posttranslational modifications.
Topics: Acetylation; Androgens; Blotting, Western; Cell Line; Cell Line, Tumor; Disease Progression; Electrophoresis, Polyacrylamide Gel; Epithelium; Humans; Male; Microscopy, Fluorescence; Peptide Synthases; Polyglutamic Acid; Prostate; Prostatic Neoplasms; Protein Processing, Post-Translational; Receptors, Androgen; Tubulin; Tyrosine | 2006 |
Immunohistochemical evidence of inducible nitric oxide synthase and nitrotyrosine in a case of clinically isolated optic neuritis.
Topics: Astrocytes; Biomarkers; Cyclooxygenase 2; Disease Progression; Humans; Immunohistochemistry; In Vitro Techniques; Male; Microglia; Myelin Basic Protein; Nitric Oxide Synthase Type II; Optic Neuritis; Prognosis; Tyrosine | 2006 |
Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Disease Progression; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-met; Retrospective Studies; Tumor Cells, Cultured; Tyrosine | 2006 |
Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.
Topics: Benzodiazepinones; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Disease Progression; Enzyme Activation; Female; Focal Adhesion Protein-Tyrosine Kinases; Gastrins; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; In Situ Hybridization; Male; Middle Aged; Oligonucleotides, Antisense; Phenylurea Compounds; Phosphorylation; Receptor, Cholecystokinin B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Tyrosine | 2006 |
Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementia.
Topics: AIDS Dementia Complex; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Bridged-Ring Compounds; Caspase 3; Cerebral Cortex; Cytochromes c; Disease Progression; Gerbillinae; Humans; Lamivudine; Male; Mitochondria; Nerve Tissue Proteins; Neuroprotective Agents; Norbornanes; Oxidation-Reduction; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Inhibitors; Synaptosomes; Thiocarbamates; Thiones; Tyrosine; Zalcitabine | 2007 |
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections.
Topics: Acute Disease; Arginine; Bacterial Infections; Biomarkers; Blood Pressure; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Chromatography, High Pressure Liquid; Creatinine; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycoproteins; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Nitric Oxide Synthase; Protein Precursors; Severity of Illness Index; Tyrosine | 2007 |
Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
Topics: Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Disease Models, Animal; Disease Progression; Gliosis; Mice; Mice, Transgenic; Psychomotor Performance; Pyruvic Acid; Spinal Cord; Superoxide Dismutase; Survival Analysis; Tyrosine | 2007 |
Role of peroxynitrite in secondary oxidative damage after spinal cord injury.
Topics: Aldehydes; Animals; Biomarkers; Calcium Signaling; Calpain; Disease Progression; Female; Free Radical Scavengers; Free Radicals; Lipid Peroxidation; Nerve Degeneration; Nitric Oxide; Oxidative Stress; Peptide Fragments; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Spectrin; Spinal Cord Injuries; Time Factors; Tyrosine; Up-Regulation | 2007 |
Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Base Sequence; Catalytic Domain; Central Nervous System; Codon; Disease Progression; DNA Mutational Analysis; Fatal Outcome; Female; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Mutation, Missense; Superoxide Dismutase; Tyrosine | 2007 |
Which comes first: renal inflammation or oxidative stress in spontaneously hypertensive rats?
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Age Factors; Animals; Antioxidants; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; Disease Models, Animal; Disease Progression; DNA Damage; Glutathione; Hypertension; Kidney Cortex; Male; NADPH Oxidases; Nephritis; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spin Labels; Tyrosine | 2007 |
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Amnesia; Biomarkers; Brain; Cognition Disorders; Disease Progression; Early Diagnosis; Female; Hippocampus; Humans; Immunohistochemistry; Male; Nerve Tissue Proteins; Nitrates; Oxidative Stress; Parietal Lobe; Predictive Value of Tests; Prognosis; Tyrosine; Up-Regulation | 2007 |
Bilirubin oxidation provoked by nitric oxide radicals predicts the progression of acute cardiac allograft rejection.
Topics: Acute Disease; Animals; Bilirubin; Biomarkers; Blotting, Western; Dipyrone; Disease Models, Animal; Disease Progression; Free Radical Scavengers; Graft Rejection; Heart Transplantation; Heme Oxygenase-1; Immunohistochemistry; Myocardium; Nitric Oxide; Oxidation-Reduction; Prognosis; Rats; Transplantation, Homologous; Tyrosine | 2007 |
Temporal characterization of mitochondrial bioenergetics after spinal cord injury.
Topics: Aldehydes; Animals; Disease Models, Animal; Disease Progression; Energy Metabolism; Female; Free Radicals; Lipid Peroxidation; Mitochondria; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Spinal Cord; Spinal Cord Injuries; Time Factors; Tyrosine | 2007 |
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Topics: Adoptive Transfer; Animals; Antibodies, Monoclonal; Cell Adhesion; Cell Proliferation; Cells, Cultured; Cyclophosphamide; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Progression; Female; Gene Expression Regulation; Intramolecular Oxidoreductases; Islets of Langerhans; Leukocytes, Mononuclear; Macrophage Migration-Inhibitory Factors; Mice; Mice, Inbred NOD; Nitric Oxide; Nitric Oxide Synthase Type II; RNA, Messenger; Spleen; Streptozocin; Tyrosine | 2008 |
Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity.
Topics: Adult; AIDS Dementia Complex; Biomarkers; Brain; Cohort Studies; Disease Progression; Down-Regulation; Enzyme Activation; Female; Humans; Intramolecular Oxidoreductases; Lipocalins; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrosation; Oxidative Stress; Predictive Value of Tests; Substance Abuse, Intravenous; Tyrosine; Up-Regulation | 2008 |
The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Cell Proliferation; Combined Modality Therapy; Disease Progression; Female; Glioma; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stereotaxic Techniques; Tyrosine | 2008 |
ShcA signalling is essential for tumour progression in mouse models of human breast cancer.
Topics: Adaptor Proteins, Signal Transducing; Animals; Breast Neoplasms; Disease Progression; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Phosphorylation; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tyrosine | 2008 |
Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients.
Topics: Aged; Aging; Atherosclerosis; Collagen; Cyclin-Dependent Kinase Inhibitor p16; Disease Progression; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Matrix Metalloproteinase 9; Middle Aged; Proteasome Endopeptidase Complex; Tyrosine; Ubiquitin | 2008 |
Prognostic value of 18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific incidental brain lesions.
Topics: Adolescent; Adult; Aged; Brain; Child; Disease Progression; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Tyrosine | 2008 |
Malignant melanoma of the head and neck. Clinical and immunological considerations.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Neoplasm; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Israel; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Scalp; Sex Factors; Skin Neoplasms; Sunlight; Tyrosine | 1996 |
Extensive peroxynitrite activity during progressive stages of central nervous system inflammation.
Topics: Animals; Antibody Specificity; Brain; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Free Radicals; Immunohistochemistry; Lipid Peroxidation; Mice; Mice, Inbred Strains; Neuritis, Autoimmune, Experimental; Neurons; Nitrates; Nitric Oxide; Spinal Cord; Staining and Labeling; Tyrosine | 1997 |
PET studies of functional compensation in a primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Progression; Dopamine Agents; Fluorine Radioisotopes; Macaca mulatta; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Neurotoxins; Pargyline; Parkinson Disease, Secondary; Tomography, Emission-Computed; Tyrosine | 1997 |
Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Topics: Adenoma; Blotting, Western; Carcinoma; Colon; Colonic Neoplasms; Disease Progression; DNA Primers; DNA, Neoplasm; Endothelial Growth Factors; Endothelium, Vascular; Humans; Immunohistochemistry; Lymphokines; Neoplasm Proteins; Neovascularization, Pathologic; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphorylation; Polymerase Chain Reaction; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Selection of the R17Y substitution in SIVmac239 nef coincided with a dramatic increase in plasma viremia and rapid progression to death.
Topics: Amino Acid Substitution; Animals; Arginine; Disease Progression; Gene Products, gag; Gene Products, nef; Macaca mulatta; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tyrosine; Viremia | 1999 |
A comparative study on neurochemistry of cerebrospinal fluid in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Brain Chemistry; Chromatography, High Pressure Liquid; Disease Progression; Dopamine; Female; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Parkinson Disease; Tyrosine | 1999 |
Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
Topics: Amyloid Neuropathies; Amyloidosis; Cardiomyopathies; Disease Progression; Humans; Liver Transplantation; Male; Middle Aged; Mutation; Prealbumin; Tyrosine | 1999 |
First gene involved in glioblastoma progression identified.
Topics: Brain Neoplasms; Cell Adhesion Molecules; Cell Division; Disease Progression; ErbB Receptors; Glioblastoma; Humans; Microfilament Proteins; Phosphorylation; Tensins; Tyrosine | 1999 |
Serum type III procollagen in children with type I hereditary tyrosinemia.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Biomarkers; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Procollagen; Tyrosine | 1999 |
Increased protein nitrosylation in head and neck squamous cell carcinogenesis.
Topics: Adult; Analysis of Variance; Carcinoma, Squamous Cell; Culture Techniques; Disease Progression; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Proteins; Nitric Oxide; Reference Values; Staining and Labeling; Statistics, Nonparametric; Tyrosine | 2000 |
Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression.
Topics: 3T3 Cells; Animals; Disease Models, Animal; Disease Progression; DNA Replication; Hydrolysis; Mice; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Rabbits; Receptor, Platelet-Derived Growth Factor alpha; Signal Transduction; src-Family Kinases; Tyrosine; Ubiquitin-Protein Ligases; Vitreoretinopathy, Proliferative | 2000 |
Expression of the inducible isoform of nitric oxide synthase in pigment cell lesions of the skin.
Topics: Biomarkers, Tumor; Disease Progression; Enzyme Induction; Humans; Isoenzymes; Macrophages; Melanoma; Neoplasm Metastasis; Nevus; Nitric Oxide Synthase; Skin Neoplasms; Tyrosine | 2000 |
Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.
Topics: Animals; Arthritis; Body Weight; Cattle; Chromonar; Collagen; Cyclooxygenase 2; Disease Progression; Enzyme Activation; Hindlimb; Interleukin-1; Isoenzymes; Male; Malondialdehyde; Nitric Oxide; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Radiography; Rats; Rats, Inbred Lew; Severity of Illness Index; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine | 2000 |
Oxidative damage is the earliest event in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Brain; Disease Progression; Female; Genotype; Guanosine; Heterozygote; Humans; Male; Middle Aged; Neurofibrillary Tangles; Neurons; Oxidative Stress; Plaque, Amyloid; Tyrosine | 2001 |
Hemochromatosis gene variants in patients with cardiomyopathy.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Cardiomyopathies; Cysteine; Disease Progression; Female; Genotype; Heart Failure; Hemochromatosis; Histidine; Humans; Logistic Models; Male; Middle Aged; Mutation, Missense; Prognosis; Tyrosine | 2001 |
COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Antiparkinson Agents; Benzophenones; Catechol O-Methyltransferase Inhibitors; Dihydroxyphenylalanine; Disease Progression; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Nitrophenols; Parkinson Disease; Tolcapone; Tyrosine | 2002 |
Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis.
Topics: Adult; Aged; Antioxidants; Aorta; Arteriosclerosis; Cholesterol; Cholesterol Esters; Disease Progression; Humans; Lipid Metabolism; Middle Aged; Oxidation-Reduction; Phenylalanine; Proteins; Tyrosine | 2002 |
Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues.
Topics: Animals; Aorta; Arteriosclerosis; Cardiovascular System; Disease Progression; DNA Damage; DNA, Mitochondrial; Hypercholesterolemia; Inhalation Exposure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitochondrial ADP, ATP Translocases; Myocardium; Oxidative Stress; Risk Factors; Superoxide Dismutase; Tobacco Smoke Pollution; Tyrosine | 2002 |
Expression and activity of nitric oxide synthase isoforms in rat brain during the development of experimental allergic encephalomyelitis.
Topics: Animals; Biopterins; Brain; Calcium; Calmodulin; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Flavin-Adenine Dinucleotide; Male; NADP; Neurons; Nitric Oxide; Nitric Oxide Synthase; Protein Isoforms; Rats; Rats, Inbred Lew; RNA, Messenger; Subcellular Fractions; Tyrosine | 2002 |